Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: Duration of booster effect

Journal of Infectious Diseases

Volumn 178, Issue 5 SUPPL., 1998, Pages

  Levin, Myron J ^a   Barber, Deb ^b   Goldblatt, Eileen ^b   Jones, Michelle ^b   LaFleur, Bonnie ^b   Chan, Christina ^b   Stinson, Diane ^b   Zerbe, Gary O ^b   Hayward, Anthony R ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; VARICELLA ZOSTER VACCINE;

ADULT; AGED; CONFERENCE PAPER; DRUG RESPONSE; HERPES ZOSTER; HUMAN; IMMUNE RESPONSE; INFECTION PREVENTION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0031766167     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514264     Document Type: Conference Paper

References (14)

1. Ragozzino MW, Melton LJ III, Kurland LT, Chu CP, Perry HO. Population-based study of herpes zoster and its sequelae. Medicine 1982;61:310-6.
2. Rogers RS III, Tindall JP. Geriatric herpes zoster. J Am Geriar Soc 1971;19:495-504.
3. Miller AE. Selective decline in cellular immune response to varicella-zoster in the elderly. Neurology 1980;30:582-7.
4. Berger R, Florent G, Just M. Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged. Infect Immun 1981;32:24-7.
5. Burke BL, Steele RW, Beard OW. Immune responses to varicella-zoster in the aged. Arch Intern Med 1982;142:291-3.
6. Levin MJ, Hayward AR. Prevention of herpes zoster. Infect Dis Clin North Am 1996;10:657-75.
7. Levin MJ, Murray M, Rotbart HA, Zerbe GO, Hayward AR, White CJ. Immune response of elderly individuals to a live attenuated varicella vaccine. J Infect Dis 1992;166:253-9.
8. Levin MJ, Murray M, Zerbe GO, White CJ, Hayward AR. Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine. J Infect Dis 1994;170:522-6.
9. Henry C, Marbrook J, Vann DC, Kodlin D, Wojsy C. Limiting dilution analysis. In: Mishell BB, Shiigi SM, eds. Selected methods in cellular immunology. San Francisco: Freeman Press, 1980;138-45.
10. McCullagh P, Nelder JA. In: Generalized linear models. New York: Chapman and Hall, 1989.
11. Hirst K, Zerbe GO, Boyle DW, Wilkening RB. On nonlinear random effects models for repeated measurements. Communications Stat 1991; B20:463-78.
12. Hayward A, Levin MJ, Wolf W, Angelova G. Varicella-zoster virus - specific immunity after herpes zoster. J Infect Dis 1991;163:873-5.
13. Zhang Y, Cosyns M, Levin MJ, Hayward AR. Cytokine production in varicella zoster virus stimulated limiting dilution lymphocyte cultures. Clin Exp Immunol 1994;98:128-33.
14. Hayward AR, Buda K, Jones M, White CJ, Levin MJ. Varicella zoster virus-specific cytotoxicity following secondary immunization with live or killed vaccine. Viral Immunol 1996;9:241-5.